Vasopressin & SNP Flashcards

1
Q

Arginine vasopressin

A

endogenous hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ADH

A

produced in hypothalamus stores in posterior pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ADH role

A

osmoregulation: release stimulated by increased osmolarity and hypovolemia
potent vasoconstrictor, but dilates renal afferent, pulmonary and cerebral arterioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 Types Vasopressin Receptors

A

V1, V2, V3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

V1

A

mediates vasoconstriction (vasculature)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

V2

A

mediates water reabsorption in the renal collecting ducts (kidney)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

V3

A

found in CNS and stimulates modulation of corticotrophin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Vasopressin Uses

A
post cardiopulm bypass shock 
refractory hypotension (ACE & ARB DOS) 
Reduce bleeding in VWB disease 
anti-diuresis in DI 
treatment of enuresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Vasopressin Dosage

A
low dose infusion: 0.03-0.04 units/min, max 0.1 units/min
bolus IV 1-2 units
onset: 1-5 min 
DOA: 10-30 min 
peak effect: 5 min
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vasopressin Complications

A

only seen at dosages >0.04 units/min
GI ischemia
decreased CO
skin or digital necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Peripheral Vasodilators: SNP

A

direct acting, nonselective peripheral vasodilator
relaxation of arterial and venous VSM
lacks significant effects on nonvascular SM and cardiac muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SNP MOA

A

SNP interacts with oxyhemoglobin to form methemoglobin, NO and cyanide
NO activates guanylate cyclase (increasing cGMP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SNP Metabolism

A

transfer of an electron from iron of oxyhemoglobin to SNP yields metHgb and an UNSTABLE SNP radical, this breaks down to release 5 cyanide ions.
ONE cyanide ion interacts with metHGB to form cyano-methemoglobin (nontoxic)
remainder metabolized in liver and kidney and converted to thiocyanate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SNP Toxicity

A

occurs due to the effects of high plasma concentrations of THIOCYANATE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cyanide Toxicity

A

occurs at rates >2mcg/kg/min for LONG PERIODS
suspect this when patients have resistance to hypotensive effects or previously responsive patient who is unresponsive (tachyphylaxis) rates >2-10 mcg/kg/min
May precipitate tissue anoxia, anaerobic metabolism and lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Thiocyanate Toxicity

A

rare, cleared by kidney in 3-7 days
less toxic than cyanide
S/S: N/V tinnutis, fatigue, CNS hyperrflexia, confusion, psychosis, miosis, seizure and coma

17
Q

SNP Dosage

A
0.3 mcg/kg/min- 10 mcg/kg/min IV 
do not infuse >10 min 
immediate onset, short DOA 
extremely potent, monitor BP with aline 
requires continuous IV admin to maintain therapeutic effect
18
Q

SNP Effects CV

A
venous and arterial vasodilation 
decreased venous capacitance d/t VR 
Increase HR (baroreflex) 
decrease SBP, SVR, PVR
increased contractility 
decreased diastolic BP, reduced coronary perfusion
19
Q

Clinical uses SNP

A

controlled hypotension: 0.3-0.5 mcg/kg/min (max 2mcg/kg/min)
hypertensive crisis: infusion 1-2mcg/kg IV (bolus also)
cardiac disease: decreases LV afterload, benefits management of MR or AR, CHF, and HF
consider coronary steal

20
Q

cGMP role

A

inhibits calcium entry into VSMC but increases uptake of calcium into the smooth ER.
Results in vasodilation via NO

21
Q

Cyanide Toxicity Tx

A

D/C SNP ASAP
100% FIO2 (even though sat is good)
Sodium bicarb
Sodium thiosulfate 150mg/kg over 15 min (sulfur donor to convert cyanide to thiocyanate
sodium nitrate 5mg/kg for SEVERE TOXICITY (coverts hemoglobin to metHgb which converts cyanide to cyanometHemoglobin

22
Q

SNP Effects CNS

A

increased CBF and ICP

modest decrease in MAP or with greater decrease in MAP can reduce CBF (caution with carotid disease)

23
Q

SNP Effects Pulmonary

A

attenuation of HPV

24
Q

SNP Effects Blood

A

increased intracellular cGMP leads to inhibition of platelet aggregation and increase bleeding time.

25
Q

Methemoglobinemia

A

rare, consider differential diagnosis with pts having impaired oxygenation despite adequate CO and arterial oxygenation

26
Q

Phototoxicity

A

SNP mix with 5% glucose in water, protect from light
if exposed to light, SNP converts to something that releases hydrogen cyanide
wrap in foil or dark plastic bag

27
Q

Toxicity

A

in the presence of renal disease and liver disease